Scientists reprogram immune cells to fight heart scarring
NCT ID NCT06902896
Summary
This early-stage study is testing whether modified immune cells can help people with severe heart failure. Researchers take patients' own immune cells, engineer them to target scar tissue in the heart, and then return them to the body. The main goal is to check if this approach is safe while also looking for signs it might improve heart function in 9 participants with advanced dilated cardiomyopathy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, 310009, China
Conditions
Explore the condition pages connected to this study.